Format
Sort by
Items per page

Send to

Choose Destination

Best matches for Källander CF[au]:

Search results

Items: 47

1.

Decreased phenotypic susceptibility to etravirine in patients with predicted genotypic sensitivity.

Agneskog E, Nowak P, Maijgren Steffensson C, Casadellà M, Noguera-Julian M, Paredes R, Källander CF, Sönnerborg A.

PLoS One. 2014 Jul 7;9(7):e101508. doi: 10.1371/journal.pone.0101508. eCollection 2014.

2.

Evaluation of etravirine resistance in clinical samples by a simple phenotypic test.

Agneskog E, Nowak P, Källander CF, Sönnerborg A.

J Med Virol. 2013 Apr;85(4):703-8. doi: 10.1002/jmv.23507. Epub 2013 Jan 30.

PMID:
23364785
3.

Reverse transcriptase viral load correlates with RNA in SIV/SHIV-infected macaques.

Corrigan GE, Hansson EO, Mörner A, Berry N, Källander CF, Thorstensson R.

AIDS Res Hum Retroviruses. 2006 Sep;22(9):917-23.

PMID:
16989619
4.

Improved HIV-1 viral load determination based on reverse transcriptase activity recovered from human plasma.

Malmsten A, Shao XW, Sjödahl S, Fredriksson EL, Pettersson I, Leitner T, Källander CF, Sandström E, Gronowitz JS.

J Med Virol. 2005 Jul;76(3):291-6.

PMID:
15902697
5.

Reverse transcriptase-based DNA vaccines against drug-resistant HIV-1 tested in a mouse model.

Isaguliants MG, Zuber B, Boberg A, Sjöstrand D, Belikov SV, Rollman E, Zuber AK, Rechinsky VO, Rytting AS, Källander CF, Hinkula J, Kochetkov SN, Liu M, Wahren B.

Vaccine. 2004 Apr 16;22(13-14):1810-9.

PMID:
15068865
6.

Mutations conferring drug resistance affect eukaryotic expression of HIV type 1 reverse transcriptase.

Isaguliants MG, Belikov SV, Starodubova ES, Gizatullin RZ, Rollman E, Zuber B, Zuber AK, Grishchenko OI, Rytting AS, Källander CF, Kochetkov SN, Karpov VL, Wahren B.

AIDS Res Hum Retroviruses. 2004 Feb;20(2):191-201.

PMID:
15018707
7.

HIV-1 viral load determination based on reverse transcriptase activity recovered from human plasma.

Malmsten A, Shao XW, Aperia K, Corrigan GE, Sandström E, Källander CF, Leitner T, Gronowitz JS.

J Med Virol. 2003 Nov;71(3):347-59.

PMID:
12966539
8.

Use of HIV-1 reverse transcriptase recovered from human plasma for phenotypic drug susceptibility testing.

Shao XW, Malmsten A, Lennerstrand J, Sönnerborg A, Unge T, Gronowitz JS, Källander CF.

AIDS. 2003 Jul 4;17(10):1463-71.

PMID:
12824784
9.

Application of a colorimetric chain-termination assay for characterization of reverse transcriptase from 3'-azido-2',3'-deoxythymidine-resistant HIV isolates.

Shao XW, Hjalmarsson S, Lennerstrand J, Svennerholm B, Blomberg J, Källander CF, Gronowitz JS.

Biotechnol Appl Biochem. 2002 Jun;35(3):155-64.

PMID:
12074693
10.

Monoclonal antibodies to native HIV type 1 reverse transcriptase and their interaction with enzymes from different subtypes.

Rytting AS, Akerblom L, Albert J, Unge T, Björling E, Al-Khalili L, Gronowitz JS, Källander CF.

AIDS Res Hum Retroviruses. 2000 Sep 1;16(13):1281-94.

PMID:
10957725
11.

Colorimetric capture assay for human-immunodeficiency-virus-I reverse transcriptase activity.

Rytting AS, Akerblom L, Gronowitz JS, Källander CF.

Biotechnol Appl Biochem. 1999 Jun;29 ( Pt 3):241-50.

PMID:
10334955
12.

Colorimetric assays for evaluation of the mode of action of human immunodeficiency virus type 1 non-nucleoside reverse transcriptase inhibitors.

Shao X, Rytting AS, Ekstrand DH, Vrang L, Källander CF, Gronowitz JS.

Antivir Chem Chemother. 1998 Mar;9(2):167-76.

PMID:
9875388
13.

A colorimetric reverse transcriptase assay optimized for Moloney murine leukemia virus, and its use for characterization of reverse transcriptases of unknown identity.

Malmsten A, Ekstrand DH, Akerblom L, Gronowitz JS, Källander CF, Bendinelli M, Matteucci D.

J Virol Methods. 1998 Nov;75(1):9-20.

PMID:
9820570
14.

Differences in reverse transcriptase activity versus p24 antigen detection in cell culture, when comparing a homogeneous group of HIV type 1 subtype B viruses with a heterogeneous group of divergent strains.

Corrigan GE, Al-Khalili L, Malmsten A, Thorstensson R, Fenyö EM, Källander CF, Gronowitz JS.

AIDS Res Hum Retroviruses. 1998 Mar 1;14(4):347-52.

PMID:
9519896
15.
17.

A method for combined immunoaffinity purification and assay of HIV-1 reverse transcriptase activity useful for crude samples.

Lennerstrand J, Rytting AS, Orvell C, Gronowitz JS, Kallander CF.

Anal Biochem. 1996 Mar 15;235(2):141-52.

PMID:
8833322
18.

HIV-1 reverse transcriptase inhibiting antibody titer in serum: relation to disease progression and to core-antibody levels.

Neumüller M, Karlsson A, Lennerstrand J, Källander CF, Sandström E, Holmberg V, Gronowitz JS.

J Med Virol. 1992 Apr;36(4):283-91.

PMID:
1374456
19.

HIV reverse transcriptase inhibiting antibodies detected by a new technique: relation to p24 and gp41 antibodies, HIV antigenemia and clinical variables.

Neumüller M, Karlsson A, Lennerstrand J, Källander CF, Holmberg V, Långström-Persson U, Thorstensson R, Sandström E, Gronowitz JS.

J Med Virol. 1991 May;34(1):55-63.

PMID:
1715898
20.

Carrier bound templates for single tube reverse transcriptase assays and for combined purification and activity analyses, with special reference to HIV.

Gronowitz JS, Neumüller M, Lennerstrand J, Bhikhabhai R, Unge T, Weltman H, Källander CF.

Biotechnol Appl Biochem. 1991 Feb;13(1):127-42.

PMID:
1711325
21.

Clinical and serologic markers of stage and prognosis in small cell lung cancer. A multivariate analysis.

Gronowitz JS, Bergström R, Nôu E, Påhlman S, Brodin O, Nilsson S, Källander CF.

Cancer. 1990 Aug 15;66(4):722-32.

PMID:
2167141
23.

Molecular forms in human serum of enzymes synthesizing DNA precursors and DNA.

Karlström AR, Neumüller M, Gronowitz JS, Källander CF.

Mol Cell Biochem. 1990 Jan 18;92(1):23-35.

PMID:
2155379
24.

Antibodies against varicella-zoster virus and herpes simplex virus deoxythymidine kinase in heterologous infections.

Källander CF, Torfason EG, Olding-Stenkvist E, Sundqvist VA, Diderholm H, Gronowitz JS.

J Med Virol. 1989 May;28(1):30-7.

PMID:
2542443
25.

Varicella zoster virus deoxythymidine kinase is present in serum before the onset of varicella.

Källander CF, Gronowitz JS, Olding-Stenkvist E.

Scand J Infect Dis. 1989;21(3):255-7.

PMID:
2547243
26.
27.

Serum thymidine-kinase and cytomegalovirus-specific antibodies after renal transplantation.

Tufveson G, Tötterman TH, Källander CF, Hagström A, Gronowitz JS.

Transplant Proc. 1988 Jun;20(3):405-7. No abstract available.

PMID:
2837850
28.

Biochemical markers in multiple myeloma: a multivariate analysis.

Simonsson B, Källander CF, Brenning G, Killander A, Gronowitz JS, Bergström R.

Br J Haematol. 1988 May;69(1):47-53.

PMID:
3289607
29.

Serum deoxythymidine kinase correlates with peripheral lymphocyte thymidine uptake in chronic lymphocytic leukemia.

Källander CF, Simonsson B, Gronowitz JS, Nilsson K.

Eur J Haematol. 1987 Apr;38(4):331-7.

PMID:
3609253
30.

Serum deoxythymidine kinase in small cell carcinoma of the lung. Relation to clinical features, prognosis, and other biochemical markers.

Gronowitz JS, Steinholtz L, Källander CF, Hagberg H, Bergh J.

Cancer. 1986 Jul 1;58(1):111-8.

PMID:
3011236
31.

Acyclic guanosine analogs as substrates for varicella-zoster virus thymidine kinase.

Karlström AR, Källander CF, Abele G, Larsson A.

Antimicrob Agents Chemother. 1986 Jan;29(1):171-4.

32.

Serum thymidine kinase in transplant patients: its relation to cytomegalovirus activity, renal transplant rejection and its use for monitoring of antiviral therapy.

Gronowitz JS, Larsson A, Källander CF, Claesson K, Sjöberg O, Lernestedt JO, Frödin L, Tufveson G.

Ann Clin Res. 1986;18(2):71-5.

PMID:
3013074
33.

Thymidine kinase in extracts of human brain tumours.

Persson L, Gronowitz SJ, Källander CF.

Acta Neurochir (Wien). 1986;80(3-4):123-7.

PMID:
3012969
34.

Deoxythymidine kinase, a possible marker for monitoring activity of cytomegalovirus infection after renal transplantation.

Larson A, Frödin L, Tufveson G, Larsson E, Källander CF, Gronowitz JS.

Scand J Urol Nephrol. 1986;20(1):75-6.

PMID:
3010448
35.

Mothers of children with Down syndrome have higher herpes simplex virus type 2 (HSV-2) antibody levels.

Annerén G, Gronowitz JS, Källander CF, Sundqvist VA.

Hum Genet. 1986 Jan;72(1):9-14.

PMID:
3002957
36.

Evaluation of serum deoxythymidine kinase as a marker in multiple myeloma.

Simonsson B, Källander CF, Brenning G, Killander A, Ahre A, Gronowitz JS.

Br J Haematol. 1985 Oct;61(2):215-24.

PMID:
4041368
37.

Serum deoxythymidine kinase gives prognostic information in chronic lymphocytic leukemia.

Källander CF, Simonsson B, Hagberg H, Gronowitz JS.

Cancer. 1984 Dec 1;54(11):2450-5.

PMID:
6498737
38.

Deoxythymidine-kinase in cerebrospinal fluid: a new potential "marker" for brain tumours.

Gronowitz JS, Källander CF, Hagberg H, Persson L.

Acta Neurochir (Wien). 1984;73(1-2):1-12.

PMID:
6093445
39.
40.
41.

A sensitive assay for detection of deoxythymidine kinase and its application to herpesvirus diagnosis.

Gronowitz JS, Källander CF.

Curr Top Microbiol Immunol. 1983;104:235-45. Review. No abstract available.

PMID:
6307593
42.

Human serum antibodies to varicella-zoster virus thymidine kinase.

Källander CF, Gronowitz JS, Torfason EG.

Infect Immun. 1982 Apr;36(1):30-7.

43.
44.
45.
46.

Occurrence of antibodies against herpes simplex virus thymidine kinase in human sera.

Gronowitz JS, Källander CF.

J Med Virol. 1981;8(3):177-86.

PMID:
6276503

Supplemental Content

Loading ...
Support Center